Agios Pharmaceuticals, Inc. (0HB0.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 02:30PM BST
| Previous close | 31.59 |
| Open | 31.70 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 31.70 - 32.13 |
| 52-week range | 20.13 - 35.35 |
| Volume | |
| Avg. volume | 522 |
| Market cap | 14.61M |
| Beta (5Y monthly) | 0.86 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Analysts Estimate Agios Pharmaceuticals (AGIO) to Report a Decline in Earnings: What to Look Out for
Agios Pharmaceuticals (AGIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- GuruFocus.com
Director Jacqualyn Fouse Sells Shares of Agios Pharmaceuticals Inc (AGIO)
Agios Pharmaceuticals Inc (NASDAQ:AGIO), a biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of cancer and rare genetic diseases, has seen a recent insider transaction according to the latest SEC filings.
- Simply Wall St.
We Think Agios Pharmaceuticals (NASDAQ:AGIO) Can Afford To Drive Business Growth
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
© 2024 Yahoo. All rights reserved.